Skip navigation

Amgen Inc.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$22,991
Revenue Growth (%)6.14%
Net Income (US$ Millions)$7,722
Earnings Per Share (US$)$10.24
EPS Growth Rate (%)13.02%
Profit Margin33.59%
Total Equity (US$ Millions)$29,875
Return on Equity (%)27.50%
Long Term Debt (US$ Millions)$30,193
Debt To Equity Ratio (%)1.01%
Total Assets (US$ Millions)$77,626
Current Assets (US$ Millions)$46,010
Current Liabilities (US$ Millions)$11,204
Cost of Goods Sold (US$ Millions)$4,162
Inventory Turnover1.61